Hulley S B, Sherwin R, Nestle M, Lee P R
West J Med. 1981 Jul;135(1):25-33.
Should clinicians prescribe fat-controlled diets to prevent coronary heart disease (CHD), and, if so, which patients should be given this advice? In this report, we use a three-step model to explain the hypothesis that dietary fats are a cause of CHD: dietary saturated fat and cholesterol raise serum cholesterol levels (step 1), which are a cause of subclinical coronary atherosclerosis (step 2), and, in turn, clinically manifest CHD (step 3). An evaluation of the scientific evidence for each step leads us to conclude that dietary fats definitely influence the level of serum cholesterol, and that serum cholesterol is probably a cause of atherosclerosis and CHD. To determine the clinical implications, we examined the potential of various foods to keep cholesterol levels lower, as well as the projected magnitude of reduction in CHD risk. The likelihood of benefit varies among patients, ranging from uncertain or trivial (for those with lower serum cholesterol levels, those who are free of other risk factors and the elderly) to substantial (for patients with higher serum cholesterol levels, those who have other risk factors and those who are young). This analysis supports an individualized approach to clinical management; each decision to prescribe a fat-controlled diet should be a judgment that depends on art-the therapeutic philosophy of each clinician and the particular needs of each patient-as well as on science. The implication for public health policies is that they should promote rather than a uniform eating pattern for all Americans, a uniform environment that enhances individual choices. This should include efforts to educate the medical profession and the public, and more comprehensive and informative foodlabeling practices.
临床医生是否应该开出脂肪控制饮食的处方来预防冠心病(CHD)?如果是,哪些患者应该得到这样的建议?在本报告中,我们使用一个三步模型来解释饮食脂肪是冠心病病因的假设:饮食中的饱和脂肪和胆固醇会提高血清胆固醇水平(第一步),这是亚临床冠状动脉粥样硬化的病因(第二步),进而导致临床显性冠心病(第三步)。对每一步科学证据的评估使我们得出结论,饮食脂肪肯定会影响血清胆固醇水平,并且血清胆固醇可能是动脉粥样硬化和冠心病的病因。为了确定临床意义,我们研究了各种食物降低胆固醇水平的潜力,以及冠心病风险预计降低的幅度。获益的可能性因患者而异,从不确定或微不足道(对于血清胆固醇水平较低、没有其他风险因素的人和老年人)到显著(对于血清胆固醇水平较高、有其他风险因素的人和年轻人)。这一分析支持临床管理的个性化方法;每一个开出脂肪控制饮食处方的决定都应该是一种判断,它取决于技艺——每位临床医生的治疗理念和每位患者的特殊需求——以及科学。对公共卫生政策的启示是,它们应该促进而不是为所有美国人推行统一的饮食模式,而是一个增强个人选择的统一环境。这应该包括努力教育医学界和公众,以及采用更全面、信息更丰富的食品标签做法。